152 related articles for article (PubMed ID: 30390725)
1. An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt.
El-Nabarawy EA; Elmasry MF; El Lawindi MI; Tarek YA
Acta Dermatovenerol Croat; 2018 Oct; 26(3):233-242. PubMed ID: 30390725
[TBL] [Abstract][Full Text] [Related]
2. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
4. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.
Tangamornsuksan W; Lohitnavy M
JAMA Dermatol; 2018 Apr; 154(4):441-446. PubMed ID: 29541744
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
Choon SE; Lai NM
Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
[TBL] [Abstract][Full Text] [Related]
6. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous cutaneous adverse drug reaction reports-An analysis of a 10-year dataset in Singapore.
Wong SX; Tham MY; Goh CL; Cheong HH; Chan SY
Pharmacol Res Perspect; 2019 Apr; 7(2):e00469. PubMed ID: 30911397
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
[TBL] [Abstract][Full Text] [Related]
10. CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
Boonyagars L; Hirunwiwatkul P; Hurst CP
Int J Tuberc Lung Dis; 2017 Mar; 21(3):338-344. PubMed ID: 28225346
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
12. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
13. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.
Dimri D; Raina RS; Thapliyal S; Thawani V
J Clin Diagn Res; 2016 May; 10(5):FC01-6. PubMed ID: 27437240
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
MachoĊ N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
17. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
Jha N; Alexander E; Kanish B; Badyal DK
Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in the Risk of Cutaneous Adverse Drug Reactions Induced by Antiseizure Medications: A Systematic Review and Meta-analysis.
Alfares I; Javaid MS; Chen Z; Anderson A; Antonic-Baker A; Kwan P
CNS Drugs; 2021 Feb; 35(2):161-176. PubMed ID: 33580477
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals.
Fang WC; Adler NR; Graudins LV; Goldblatt C; Goh MSY; Roberts SK; Trubiano JA; Aung AK
Intern Med J; 2018 May; 48(5):549-555. PubMed ID: 29316113
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
Mittal N; Gupta M; Singla M
Cutan Ocul Toxicol; 2014 Dec; 33(4):289-93. PubMed ID: 24517496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]